Free Trial

Belite Bio (BLTE) Short Interest Ratio & Short Volume

Belite Bio logo
$61.48 -0.82 (-1.32%)
As of 04/30/2025 04:00 PM Eastern

Belite Bio Short Interest Data

Belite Bio (BLTE) has a short interest of 60,700 shares, representing 0.22% of the float (the number of shares available for trading by the public). This marks a -13.29% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.5, indicating that it would take 1.5 days of the average trading volume of 50,465 shares to cover all short positions.

Current Short Interest
60,700 shares
Previous Short Interest
70,000 shares
Change Vs. Previous Month
-13.29%
Dollar Volume Sold Short
$3.57 million
Short Interest Ratio
1.5 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
31,838,000 shares
Short Percent of Float
0.22%
Today's Trading Volume
10,711 shares
Average Trading Volume
50,465 shares
Today's Volume Vs. Average
21%
Short Selling Belite Bio?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Belite Bio and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BLTE Short Interest Over Time

BLTE Days to Cover Over Time

BLTE Percentage of Float Shorted Over Time

Belite Bio Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/202560,700 shares $3.57 million -13.3%0.2%1.5 $58.88
3/31/202570,000 shares $4.64 million -21.5%0.3%1.6 $66.22
3/15/202589,200 shares $6.02 million +9.7%0.3%2.1 $67.44
2/28/202581,300 shares $4.65 million +17.2%0.3%1.8 $57.20
2/15/202569,400 shares $3.89 million +8.8%0.3%1.6 $56.00
1/31/202563,800 shares $3.70 million -9.3%N/A1.1 $58.04
1/15/202570,300 shares $3.86 million -12.6%N/A1 $54.90
12/31/202480,400 shares $5.07 million -60.3%N/A1.1 $63.10
12/15/2024202,300 shares $12.61 million -12.9%N/A2.8 $62.34
11/30/2024232,300 shares $14.70 million -3.7%N/A3.3 $63.26
11/15/2024241,100 shares $19.97 million +3.0%N/A3.8 $82.81
10/31/2024234,000 shares $15.59 million -13.5%N/A4.5 $66.61
10/15/2024270,600 shares $15.00 million -1.1%N/A8.3 $55.45
9/30/2024273,500 shares $12.82 million -2.5%N/A8.9 $46.88
9/15/2024280,400 shares $13.69 million +3.8%N/A8.3 $48.82
8/31/2024270,200 shares $13.15 million -5.1%N/A6.1 $48.68
8/15/2024284,800 shares $14.21 million -9.6%N/A5.7 $49.90
7/31/2024315,200 shares $15.60 million +10.7%N/A5.9 $49.50
7/15/2024284,700 shares $13.95 million +28.0%N/A5.1 $49.00
6/30/2024222,500 shares $10.16 million +516.3%N/A4.2 $45.68
6/15/202436,100 shares $1.80 million -22.9%N/A0.7 $49.96
5/31/202446,800 shares $2.29 million +32.2%N/A1.1 $48.95
5/15/202435,400 shares $1.50 million +87.3%N/A0.9 $42.45
4/30/202418,900 shares $767,340.00 -44.4%N/A0.5 $40.60
4/15/202434,000 shares $1.24 million -13.0%N/A0.7 $36.40
3/31/202439,100 shares $1.50 million -34.3%N/A0.6 $38.37
3/15/202459,500 shares $2.29 million +20.7%N/A0.8 $38.47
2/29/202449,300 shares $2.28 million +4.5%N/A0.6 $46.25
2/15/202447,200 shares $2.27 million -11.3%N/A0.5 $48.00
1/31/202453,200 shares $2.31 million -6.0%N/A0.5 $43.43
1/15/202456,600 shares $2.59 million +40.8%N/A0.4 $45.81
12/31/202340,200 shares $1.84 million -47.9%N/A0.3 $45.75
12/15/202377,100 shares $3.46 million +19.5%N/A0.6 $44.83
11/30/202364,500 shares $2.71 million -26.3%N/A0.5 $42.07
11/15/202387,500 shares $3.24 million -9.7%N/A0.7 $37.02
10/31/202396,900 shares $3.63 million +172.2%N/A0.8 $37.51
10/15/202335,600 shares $1.14 million -5.3%N/A0.4 $32.00
9/30/202337,600 shares $1.20 million -14.9%N/A0.5 $31.85
9/15/202344,200 shares $1.42 million +17.9%N/A0.5 $32.20
8/31/202337,500 shares $1.29 million +7.1%N/A0.5 $34.35
The Worst Year in American Financial History? (Ad)

Economist Explains: The Curse on the U.S. Dollar Yes, there is a Curse on the U.S. Dollar... and it's behind all the chaos you've seen play out in the global economy in 2025. This curse has nothing to do with astrology or anything metaphorical. In fact, it's studied at the highest levels of finance and academia ... and VP Vance even questioned Jerome Powell about it. It's a wild money story you could soon hear everywhere. Only one investigative journalist is telling the story here.

Learn the #1 move to protect your wealth now
8/15/202335,000 shares $775,950.00 -24.1%N/A0.5 $22.17
7/31/202346,100 shares $1.07 million +30.6%N/A0.8 $23.22
7/15/202335,300 shares $474,432.00 -26.6%N/A0.7 $13.44
6/30/202348,100 shares $678,691.00 +13.7%N/A1.4 $14.11
6/15/202342,300 shares $607,005.00 +60.8%N/A1.4 $14.35
5/31/202326,300 shares $433,687.00 -3.3%N/A1 $16.49
5/15/202327,200 shares $639,200.00 -18.6%N/A2.3 $23.50
4/30/202333,400 shares $966,262.00 +5.4%N/A3.1 $28.93
4/15/202331,700 shares $911,375.00 +13.6%N/A3 $28.75
3/31/202327,900 shares $834,207.21 -24.4%N/A2.7 $29.90
3/15/202336,900 shares $1.13 million -4.9%N/A3.2 $30.50
2/28/202338,800 shares $1.28 million +1.8%N/A3.6 $33.10
2/15/202338,100 shares $1.22 million -8.9%N/A3 $32.00
1/31/202341,800 shares $1.25 million -52.8%N/A3.2 $29.89
1/15/202388,600 shares $2.53 million -12.1%N/A4.9 $28.50
12/30/2022100,800 shares $3.04 million -1.4%N/A4.8 $30.15
12/15/2022102,200 shares $3.04 million -13.2%N/A3.9 $29.73
11/30/2022117,800 shares $3.86 million -8.8%N/A4.1 $32.77
11/15/2022129,200 shares $3.24 million -5.3%N/A3.9 $25.10
10/31/2022136,400 shares $3.97 million +5.1%N/A3.3 $29.07
10/15/2022129,800 shares $3.60 million +3.8%N/A2.9 $27.77
9/30/2022125,100 shares $4.20 million -11.3%N/A2.1 $33.55
9/15/2022141,100 shares $5.02 million -5.5%N/A2 $35.55
8/31/2022149,300 shares $4.79 million +30.1%N/A1.7 $32.11
8/15/2022114,800 shares $3.50 million +14.1%N/A1.4 $30.50
7/31/2022100,600 shares $3.38 million -9.2%N/A1 $33.60
7/15/2022110,800 shares $4.66 million No ChangeN/A0.3 $42.07

BLTE Short Interest - Frequently Asked Questions

What is Belite Bio's current short interest?

Short interest is the volume of Belite Bio shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 60,700 shares of BLTE short. 0.22% of Belite Bio's shares are currently sold short. Learn More on Belite Bio's current short interest.

What is a good short interest ratio for Belite Bio?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BLTE shares currently have a short interest ratio of 2.0. Learn More on Belite Bio's short interest ratio.

What is a good short interest percentage for Belite Bio?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.22% of Belite Bio's floating shares are currently sold short.

Is Belite Bio's short interest increasing or decreasing?

Belite Bio saw a decrease in short interest in April. As of April 15th, there was short interest totaling 60,700 shares, a decrease of 13.3% from the previous total of 70,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Belite Bio's short interest compare to its competitors?

0.22% of Belite Bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Belite Bio: Lantheus Holdings, Inc. (10.23%), Revolution Medicines, Inc. (10.62%), BridgeBio Pharma, Inc. (15.57%), Legend Biotech Co. (5.49%), TG Therapeutics, Inc. (16.90%), Blueprint Medicines Co. (9.08%), Sarepta Therapeutics, Inc. (7.51%), Axsome Therapeutics, Inc. (11.68%), Nuvalent, Inc. (14.61%), Verona Pharma plc (10.22%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Belite Bio stock?

Short selling BLTE is an investing strategy that aims to generate trading profit from Belite Bio as its price is falling. BLTE shares are trading down $0.82 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Belite Bio?

A short squeeze for Belite Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BLTE, which in turn drives the price of the stock up even further.

How often is Belite Bio's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLTE, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:BLTE) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners